Kathleen Harnden, MD MBA

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    advisory board
    Date added:
    10/25/2023
    Date updated:
    02/20/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    SeaGen
    Topic:
    physician speaker
    Date added:
    10/25/2023
    Date updated:
    02/20/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    physician speaker
    Date added:
    10/25/2023
    Date updated:
    02/20/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo
    Topic:
    physician speaker
    Date added:
    10/25/2023
    Date updated:
    02/20/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astrazeneca
    Topic:
    physician speaker
    Date added:
    10/25/2023
    Date updated:
    02/20/2025
Return to 2025 Inova Schar Cancer Institute Grand Rounds: Oligometastatic Breast Cancer - When to go for Cure?